Inicio>>Signaling Pathways>> Ubiquitination/ Proteasome>> Autophagy>>Glycycoumarin

Glycycoumarin

Catalog No.GC36163

Glycycoumarin es un potente agente antiespasmÓdico. Glycycoumarin es una cumarina bioactiva principal de regaliz y exhibe actividad antiespasmÓdica. Glycycoumarin también tiene efecto hepatoprotector. Glycycoumarin se puede utilizar para la investigaciÓn del dolor abdominal y enfermedades del hÍgado.

Products are for research use only. Not for human use. We do not sell to patients.

Glycycoumarin Chemical Structure

Cas No.: 94805-82-0

Tamaño Precio Disponibilidad Cantidad
1mg Please Inquire Please Inquire
5mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Glycycoumarin is a major bioactive coumarin of licorice. Glycycoumarin inhibits hepatocyte lipoapoptosis through activation of autophagy and inhibition of ER stress-mediated JNK and GSK-3-mediated mitochondrial pathway. Glycycoumarin exerts anti-liver cancer activity by directly targeting T-LAK cell-originated protein kinase [1] [2].

[1]. Zhang E, et al. Glycycoumarin inhibits hepatocyte lipoapoptosis through activation of autophagy and inhibition of ER stress/GSK-3-mediated mitochondrial pathway. Sci Rep. 2016 Nov 30;6:38138. [2]. Song X, et al. Glycycoumarin exerts anti-liver cancer activity by directly targeting T-LAK cell-originated protein kinase. Oncotarget. 2016 Oct 4;7(40):65732-65743.

Reseñas

Review for Glycycoumarin

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Glycycoumarin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.